InvestorWaves

Stories

View all stories
Line chart comparing NVIDIA buyback authorization increases from 2023 to 2026 with NVDA split-adjusted stock price. The latest point shows a $150 billion authorization and $235 billion remaining buyback capacity through fiscal 2028.
Nvidia Just Dropped a $150B Buyback
stocks

Nvidia Just Dropped a $150B Buyback

Line chart showing the CME FedWatch probability of a 25-basis-point Fed hike at the Oct. 27-28, 2026 FOMC meeting. The probability rose from 55.4% on Sept. 17 to a 70.9% peak on Sept. 23 and stood at 68.1% on Sept. 28.
Another Fed Hike Is Now the Base Case
Federal Reserve

Another Fed Hike Is Now the Base Case

Two-line chart comparing Cracker Barrel quarterly comparable-store sales growth from fiscal 2024 through fiscal 2026. Retail sales growth overtakes restaurant sales growth in the final two quarters and ends at positive 0.7%, while restaurant sales end at negative 2.1%.
Cracker Barrel's Gift Shop Just Beat the Dining Room
Consumer Stocks

Cracker Barrel's Gift Shop Just Beat the Dining Room

Historical line chart of the S&P 500 Shiller P/E from 1871 through September 2026. The current reading of 41.48 is highlighted in red near the December 1999 record of 44.19, with the long-run mean marked at 17.42.
Stocks Are Back in Dot-Com Territory
Market Valuation

Stocks Are Back in Dot-Com Territory

Chart for A Down-Trending Market

A Down-Trending Market

Chart for AI Has a Grid Backlog
AI Has a Grid Backlog

AI Has a Grid Backlog

Chart for Reddit's Stock Pickers Are Having a Monster Year. Allegedly.
Reddit's Stock Pickers Are Having a Monster Year. Allegedly.

Reddit's Stock Pickers Are Having a Monster Year. Allegedly.

Ranked dumbbell chart showing launch price versus 2026 price for standard ad-free streaming plans. Disney+ rises from $6.99 to $21.49, Apple TV+ from $4.99 to $14.99, Netflix from $7.99 to $19.99, Peacock from $9.99 to $19.99, Hulu from $11.99 to $21.49, Paramount+ from $9.99 to $13.99, and HBO Max from $14.99 to $18.49.
Streaming's Ad-Free Price Climb
Consumer

Streaming's Ad-Free Price Climb

Stock Ideas

View all ideas
GMAB

Genmab A/S

Genmab is emerging as a Biotech Therapeutics leader as sustained institutional accumulation and strong relative strength have pushed shares near a 52-week high in a confirmed uptrend.

Biotech Therapeutics
MSFT

Microsoft Corp

Microsoft's sustained mid-teens revenue growth, high institutional ownership, and leading cloud footprint position it as a timely leader in Cloud & Hosting Infrastructure themes.

Cloud & Hosting Infrastructure
NSP

Insperity, Inc.

Insperity is a leading HR outsourcing and services provider whose steady service revenue, strong institutional accumulation, and confirmed technical uptrend make it a timely enterprise HR-services leader.

Enterprise & Vertical Software
TNET

Trinet Group, Inc.

Trinet combines enterprise-focused HR services with re-accelerating GAAP quarterly EPS growth, heavy institutional ownership, and an established Stage 2 uptrend within Enterprise & Vertical Software.

Enterprise & Vertical Software
MANH

Manhattan Associates Inc

Manhattan Associates pairs accelerating revenue growth with an established Stage 2 technical uptrend, making it a timely leader in enterprise logistics and vertical software solutions.

Enterprise & Vertical Software
MEDP

Medpace Holdings, Inc.

Medpace, a clinical research services leader, combines consistent double-digit revenue growth and high institutional ownership, making it a timely leader in Life Science Tools & CDMO.

Life Science Tools & CDMO

Market insights, made visual.

Get data-driven insights into stocks and investing themes in a free newsletter that takes 5 minutes to read.